HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Zhao Selected Research

hematoporphyrin monomethyl ether

3/2021Crosstalk between oxidative stress, autophagy and apoptosis in hemoporfin photodynamic therapy treated human umbilical vein endothelial cells.
9/2018A dose-finding study for hemoporfin in photodynamic therapy for port-wine stain: A multicenter randomized double-blind phase IIb trial.
1/2016Hemoporfin Photodynamic Therapy for Port-Wine Stain: A Randomized Controlled Trial.
2/2011Efficacy and safety of hemoporfin in photodynamic therapy for port-wine stain: a multicenter and open-labeled phase IIa study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Zhao Research Topics

Disease

213Neoplasms (Cancer)
05/2022 - 04/2002
46Breast Neoplasms (Breast Cancer)
06/2022 - 11/2005
40Neoplasm Metastasis (Metastasis)
07/2022 - 04/2002
38Inflammation (Inflammations)
11/2022 - 05/2004
22Hepatocellular Carcinoma (Hepatoma)
05/2022 - 12/2005
21Stroke (Strokes)
05/2022 - 05/2007
21Rheumatoid Arthritis
12/2019 - 08/2006
20Lung Neoplasms (Lung Cancer)
05/2022 - 11/2010
19Carcinogenesis
01/2022 - 08/2003
18Infections
01/2022 - 06/2010
18Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2003
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 05/2008
15Carcinoma (Carcinomatosis)
02/2022 - 06/2002
14Multiple Myeloma
01/2022 - 01/2011
13Prostatic Neoplasms (Prostate Cancer)
07/2022 - 05/2004
13Psoriasis (Pustulosis Palmaris et Plantaris)
07/2021 - 06/2012
12Autoimmune Diseases (Autoimmune Disease)
01/2021 - 05/2007
11Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 09/2007
11Alzheimer Disease (Alzheimer's Disease)
01/2022 - 06/2011
11Leukemia
01/2020 - 05/2004
10Infarction (Infarctions)
01/2021 - 05/2004
9Adenocarcinoma of Lung
09/2022 - 01/2017
9Insulin Resistance
07/2022 - 04/2008
9Hypoxia (Hypoxemia)
06/2022 - 06/2006
9Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2013
9COVID-19
09/2021 - 01/2020
9Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2021 - 05/2004
9Arthritis (Polyarthritis)
12/2020 - 05/2007
8Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2012
8Obesity
01/2022 - 01/2012
8Hypertension (High Blood Pressure)
01/2022 - 09/2015
8Hemorrhage
10/2021 - 12/2011
8Acute Promyelocytic Leukemia
01/2021 - 05/2016
7Glioma (Gliomas)
05/2022 - 02/2019
7Fibrosis (Cirrhosis)
01/2022 - 09/2012
7Body Weight (Weight, Body)
01/2021 - 08/2012
7Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 08/2003
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2018 - 01/2012
7Ischemic Stroke
09/2017 - 01/2007
6Mitochondrial Diseases (Mitochondrial Disease)
05/2022 - 01/2017
6Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 03/2010
6Ischemia
04/2021 - 05/2004
6Port-Wine Stain (Nevus Flammeus)
03/2021 - 02/2011
6Hyperplasia
01/2021 - 01/2013
6Pain (Aches)
01/2021 - 01/2014
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 02/2011
6Liver Neoplasms (Liver Cancer)
01/2021 - 06/2002
6Hemolysis
01/2020 - 01/2018
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 02/2006

Drug/Important Bio-Agent (IBA)

65Proteins (Proteins, Gene)FDA Link
05/2022 - 04/2002
49Biomarkers (Surrogate Marker)IBA
11/2022 - 09/2010
39Pharmaceutical PreparationsIBA
01/2023 - 02/2005
23Biological ProductsIBA
06/2022 - 02/2009
21LigandsIBA
06/2022 - 05/2007
21CytokinesIBA
04/2021 - 04/2008
19Long Noncoding RNAIBA
07/2022 - 04/2013
19Messenger RNA (mRNA)IBA
01/2022 - 04/2002
18Liposomes (Liposome)IBA
06/2022 - 05/2013
18MicroRNAs (MicroRNA)IBA
05/2022 - 12/2010
17Therapeutic UsesIBA
07/2021 - 02/2005
16RNA (Ribonucleic Acid)IBA
01/2022 - 07/2007
16Small Interfering RNA (siRNA)IBA
05/2020 - 06/2007
13Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2003
12Doxorubicin (Adriamycin)FDA LinkGeneric
05/2022 - 06/2007
11Glucose (Dextrose)FDA LinkGeneric
07/2022 - 05/2007
11CateninsIBA
01/2022 - 01/2011
11Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2021 - 02/2006
10Diethylhexyl Phthalate (DEHP)IBA
04/2022 - 11/2018
10SaltsIBA
01/2022 - 11/2013
10DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2007
9LipidsIBA
10/2021 - 06/2013
9Paclitaxel (Taxol)FDA LinkGeneric
07/2021 - 01/2016
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 07/2007
8ErbB Receptors (EGF Receptor)IBA
01/2022 - 05/2008
8SodiumIBA
01/2022 - 01/2012
8AntigensIBA
01/2022 - 01/2006
8Pioglitazone (Actos)FDA Link
01/2021 - 07/2005
8Phosphotransferases (Kinase)IBA
01/2021 - 10/2006
7Hormones (Hormone)IBA
02/2022 - 11/2005
7Cisplatin (Platino)FDA LinkGeneric
01/2022 - 10/2013
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2021 - 06/2006
7Peptides (Polypeptides)IBA
01/2019 - 09/2008
7AntibodiesIBA
01/2019 - 09/2007
7Interleukin-6 (Interleukin 6)IBA
01/2019 - 11/2008
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2016
6Polysaccharides (Glycans)IBA
07/2022 - 11/2014
6Blood Glucose (Blood Sugar)IBA
07/2022 - 11/2003
6EnzymesIBA
06/2022 - 09/2007
6VaccinesIBA
09/2021 - 01/2011
6Tyrosine Kinase InhibitorsIBA
04/2021 - 01/2018
61-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2021 - 02/2011
6Neuroprotective AgentsIBA
01/2021 - 05/2004
6C-Reactive ProteinIBA
01/2021 - 09/2006
6Interleukin-23 (Interleukin 23)IBA
12/2019 - 07/2009

Therapy/Procedure

88Therapeutics
01/2023 - 06/2007
29Drug Therapy (Chemotherapy)
06/2022 - 06/2007
10Immunotherapy
02/2022 - 04/2002
9Radiotherapy
01/2022 - 04/2017
8Photochemotherapy (Photodynamic Therapy)
03/2021 - 02/2011
7Aftercare (After-Treatment)
10/2021 - 09/2015